Add to a list

Inactive Instrument

LOTUS PHARM Stock OTC Bulletin Board

LTUS

US5457151042

Pharmaceuticals

OTC Markets Traded

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

31/07/23	Amarin, Lotus Pharmaceuticals Agree to Exclusive Vazkepa Distribution Deal in 10 Asian Countries	MT
26/11/21	Thai oil firm PTT expands pharma business with $475 million Alvogen deal	RE

Lotus Pharmaceuticals Inc is a company mainly engaged in development, manufacture, and sales of pharmaceuticals. The Company produces crude medicine and drugs in forms of tablets, capsules, granules, eye-drops, and freeze-dried powder injection. The Company's drug development is focused on the treatment of cerebro-cardiovascular disease, asthma, and diabetes. The Company operated in two business segment Wholesales segment and Retail segment. The Company's products include Maixin-valsartan capsules for the treatment of hypertension, Muxineye drops for the treatment of glaucoma and Yipubishan-octreotide Acetate Injection solution for the treatment of gastric ulcers. The Company mainly conducts its businesses in the domestic market and overseas markets.

Employees

Sector

Pharmaceuticals

More about the company

Rankings

Rankings

Currency / Forex

Commodities

Cryptocurrencies

Interest Rates

The best tools reserved for subscribers to boost the performance of your investments!

Market Cap	9.74M 8.54M 7.96M 7.32M 13.72M 930M 13.95M 94.39M 36.95M 461M 36.55M 35.76M 1.59B	P/E 2009	3.88x	P/E 2010	4.84x
Enterprise Value	14.38M 12.62M 11.75M 10.81M 20.27M 1.37B 20.61M 139M 54.58M 681M 53.99M 52.83M 2.35B	EV / Sales 2009	1.02x	EV / Sales 2010	0.95x
Free-Float	99%	Yield 2009 *	-	Yield 2010	-

31/07/23	Amarin, Lotus Pharmaceuticals Agree to Exclusive Vazkepa Distribution Deal in 10 Asian Countries	MT
26/11/21	Thai oil firm PTT expands pharma business with $475 million Alvogen deal	RE
28/09/21	Lotus Pharmaceuticals : Temasek-backed Vertex expects at least $400 million in new S.E.Asia/India fund	RE
16/05/12	Lotus Pharmaceuticals, Inc. has Changed its Ticker to LTUS from LTUSE	CI
19/04/12	Lotus Pharmaceuticals, Inc. has Changed its Ticker to LTUS.E from LTUS	CI

12-30	Lotus Pharmaceutical Supports Street Medicine Program to Expand Access to Care for Those Most in Need	AQ
06/10/25	Lotus Enters License and Supply Agreement with Adalvo for Semaglutide injection	AQ
12/08/25	Lotus Pharmaceutical Achieves New First-Half Record in Revenue for 2025, While Q2 Impacted by FX and Timing of Lenalidomide Sales	AQ
21/02/25	Lotus announces FDA acceptance of Potential First-to-File ANDA Submission for Voclosporin soft gelatin capsules, a generic equivalent to Lupkynis	AQ
08/11/24	Lotus Achieves Second-Highest Quarterly Performance in Company History with 3Q24 Financial Results	AQ

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SUN PHARMACEUTICAL INDUSTRIES LTD.	+0.15%	+1.04%	+16.34%	+74.17%	49.38B
OTSUKA HOLDINGS CO., LTD.	+0.53%	+3.50%	+61.24%	+112.76%	36.35B
CIPLA LIMITED	+2.50%	+0.21%	-5.74%	+23.32%	11.87B
ZYDUS LIFESCIENCES LIMITED	-0.81%	-4.33%	+12.58%	+69.24%	11.53B
KRKA, D. D.	+0.38%	-2.06%	+34.70%	+131.86%	8.99B
ONO PHARMACEUTICAL CO., LTD.	-0.92%	-0.35%	+48.24%	-9.27%	7B
GEDEON RICHTER	-0.51%	-0.85%	+11.77%	+33.26%	6.76B
GLENMARK PHARMACEUTICALS LIMITED	-0.52%	-2.45%	+1.83%	+165.65%	6.46B
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	-1.32%	-11.87%	-32.46%	-0.24%	5.49B
Average	-0.06%	-0.95%	+16.50%	+66.75%	15.98B
Weighted average by Cap.	+0.21%	+0.32%	+25.54%	+78.22%

	2009	2010
Net sales	57.82M 50.75M 47.26M 43.46M 81.48M 5.52B 82.87M 561M 219M 2.74B 217M 212M 9.47B	72.7M 63.8M 59.41M 54.64M 102M 6.95B 104M 705M 276M 3.44B 273M 267M 11.9B
Net income	16.43M 14.42M 13.43M 12.35M 23.15M 1.57B 23.55M 159M 62.36M 779M 61.69M 60.36M 2.69B	14.42M 12.66M 11.79M 10.84M 20.33M 1.38B 20.67M 140M 54.74M 683M 54.15M 52.98M 2.36B
Net Debt	5.29 4.65 4.33 3.98 7.46 505.76 7.59 51.33 20.09 250.82 19.87 19.44 866.59	4.65 4.08 3.8 3.49 6.55 443.93 6.66 45.05 17.63 220.16 17.44 17.07 760.66

LOTUS PHARM Stock OTC Bulletin Board

Stocks

LTUS

US5457151042

Pharmaceuticals

Valuation: LOTUS PHARM

Latest news : LOTUS PHARM

Press Releases: LOTUS PHARM

Managers and Directors: LOTUS PHARM

Generic Pharmaceuticals

Financials

Company Profile